Prevalence of HTLV‐I in arctic regions

Abstract Sera of native inhabitants of Arctic regions were assayed for antibodies to HTLV‐I by the ELISA technique followed by competition experiments to confirm antibody specificity. Residents of 7 widely separated Alaskan villages exhibited prevalence rates of 0 to 12% for HTLV‐I antibodies. Less...

Full description

Bibliographic Details
Published in:International Journal of Cancer
Main Authors: Robert‐Guroff, Marjorie, Clark, Jeffrey, Lanier, Anne P., Beckman, Gunhild, Melbye, Mads, Ebbesen, Peter, Blattner, William A., Gallo, Robert C.
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 1985
Subjects:
Online Access:http://dx.doi.org/10.1002/ijc.2910360605
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910360605
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.2910360605
id crwiley:10.1002/ijc.2910360605
record_format openpolar
spelling crwiley:10.1002/ijc.2910360605 2024-06-02T07:54:43+00:00 Prevalence of HTLV‐I in arctic regions Robert‐Guroff, Marjorie Clark, Jeffrey Lanier, Anne P. Beckman, Gunhild Melbye, Mads Ebbesen, Peter Blattner, William A. Gallo, Robert C. 1985 http://dx.doi.org/10.1002/ijc.2910360605 https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910360605 https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.2910360605 en eng Wiley http://onlinelibrary.wiley.com/termsAndConditions#vor International Journal of Cancer volume 36, issue 6, page 651-655 ISSN 0020-7136 1097-0215 journal-article 1985 crwiley https://doi.org/10.1002/ijc.2910360605 2024-05-03T11:55:00Z Abstract Sera of native inhabitants of Arctic regions were assayed for antibodies to HTLV‐I by the ELISA technique followed by competition experiments to confirm antibody specificity. Residents of 7 widely separated Alaskan villages exhibited prevalence rates of 0 to 12% for HTLV‐I antibodies. Less than 1 % of Greenland Eskimos were HTLV‐I antibody‐positive. Residents of 3 northern Swedish regions ranged in HTLV‐I antibody prevalence from 0 to 5%. Sera of healthy native inhabitants of Alaska and northern Sweden were similarly assayed for antibodies to HTLV‐II. No additional sera were shown to be positive for HTLV‐II antibodies. While some of the HTLV‐I antibody‐positive sera exhibited cross‐reactivity with HTLV‐II antigens, competition experiments using disrupted HTLV‐II or purified HTLV‐I p24 as test antigens indicated that the primary antibody response in all cases tested was elicited by HTLV‐I. Our results show that HTLV‐I distribution is not restricted to endemic areas in warm, humid climates, but extends to Arctic regions. Within these regions, HTLV‐I exhibits the same restricted distribution seen in other areas where virus infection is prevalent. The Arctic does not seem to be a reservoir for HTLV‐II infection. The origin of HTLV‐I in Arctic areas is not known. One may speculate that foreign visitors introduced the virus into Aleut and Lapp populations, and that it has been maintained there and restricted in its distribution as a result of close familial relationships. Article in Journal/Newspaper aleut Arctic eskimo* Greenland Northern Sweden Alaska Wiley Online Library Arctic Greenland International Journal of Cancer 36 6 651 655
institution Open Polar
collection Wiley Online Library
op_collection_id crwiley
language English
description Abstract Sera of native inhabitants of Arctic regions were assayed for antibodies to HTLV‐I by the ELISA technique followed by competition experiments to confirm antibody specificity. Residents of 7 widely separated Alaskan villages exhibited prevalence rates of 0 to 12% for HTLV‐I antibodies. Less than 1 % of Greenland Eskimos were HTLV‐I antibody‐positive. Residents of 3 northern Swedish regions ranged in HTLV‐I antibody prevalence from 0 to 5%. Sera of healthy native inhabitants of Alaska and northern Sweden were similarly assayed for antibodies to HTLV‐II. No additional sera were shown to be positive for HTLV‐II antibodies. While some of the HTLV‐I antibody‐positive sera exhibited cross‐reactivity with HTLV‐II antigens, competition experiments using disrupted HTLV‐II or purified HTLV‐I p24 as test antigens indicated that the primary antibody response in all cases tested was elicited by HTLV‐I. Our results show that HTLV‐I distribution is not restricted to endemic areas in warm, humid climates, but extends to Arctic regions. Within these regions, HTLV‐I exhibits the same restricted distribution seen in other areas where virus infection is prevalent. The Arctic does not seem to be a reservoir for HTLV‐II infection. The origin of HTLV‐I in Arctic areas is not known. One may speculate that foreign visitors introduced the virus into Aleut and Lapp populations, and that it has been maintained there and restricted in its distribution as a result of close familial relationships.
format Article in Journal/Newspaper
author Robert‐Guroff, Marjorie
Clark, Jeffrey
Lanier, Anne P.
Beckman, Gunhild
Melbye, Mads
Ebbesen, Peter
Blattner, William A.
Gallo, Robert C.
spellingShingle Robert‐Guroff, Marjorie
Clark, Jeffrey
Lanier, Anne P.
Beckman, Gunhild
Melbye, Mads
Ebbesen, Peter
Blattner, William A.
Gallo, Robert C.
Prevalence of HTLV‐I in arctic regions
author_facet Robert‐Guroff, Marjorie
Clark, Jeffrey
Lanier, Anne P.
Beckman, Gunhild
Melbye, Mads
Ebbesen, Peter
Blattner, William A.
Gallo, Robert C.
author_sort Robert‐Guroff, Marjorie
title Prevalence of HTLV‐I in arctic regions
title_short Prevalence of HTLV‐I in arctic regions
title_full Prevalence of HTLV‐I in arctic regions
title_fullStr Prevalence of HTLV‐I in arctic regions
title_full_unstemmed Prevalence of HTLV‐I in arctic regions
title_sort prevalence of htlv‐i in arctic regions
publisher Wiley
publishDate 1985
url http://dx.doi.org/10.1002/ijc.2910360605
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910360605
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.2910360605
geographic Arctic
Greenland
geographic_facet Arctic
Greenland
genre aleut
Arctic
eskimo*
Greenland
Northern Sweden
Alaska
genre_facet aleut
Arctic
eskimo*
Greenland
Northern Sweden
Alaska
op_source International Journal of Cancer
volume 36, issue 6, page 651-655
ISSN 0020-7136 1097-0215
op_rights http://onlinelibrary.wiley.com/termsAndConditions#vor
op_doi https://doi.org/10.1002/ijc.2910360605
container_title International Journal of Cancer
container_volume 36
container_issue 6
container_start_page 651
op_container_end_page 655
_version_ 1800743127223369728